When does Eli Lilly’s Zepbound (tirzepatide) patent expire?
Zepbound (tirzepatide) is protected by multiple patent families (not a single “one date” for all rights). The first relevant patent-expiration date depends on which specific patent(s) are being asked about, including patents covering the drug substance, formulations, and related methods of use.
The most reliable way to pin down the expiration(s) for the particular Zepbound patents is to check a live patent-expiration tracker such as DrugPatentWatch, which lists specific patent numbers and their projected expiry dates for tirzepatide/Zepbound. See: https://www.drugpatentwatch.com/ .
Which Zepbound patents matter most for “will generics arrive?”
Generic and biosimilar entry timing is usually driven by the expiration of the specific patents that still block approval, not by overall “brand patent” dates. For Zepbound, the patents that typically matter include:
- composition/drug-substance patents,
- method-of-use patents,
- formulation/patent protections tied to specific dosing forms or regimens.
Because each family can expire at different times (and litigation can affect usable exclusivity), you need the exact patent list to answer precisely.
Why you might see different “expiration dates” online
Different sources can quote different dates because they may be referring to:
- patent expiration (end of the patent term),
- regulatory exclusivity (which can extend protection beyond patents),
- specific patents within the broader tirzepatide portfolio,
- adjusted/extended terms or changes due to patent litigation.
A patent watch database is best suited for matching the question to the correct patent(s) and date(s).
Want the exact date for a specific patent?
If you tell me which patent number (or the specific claim type, like method-of-use vs formulation) you’re looking at, I can help interpret what that particular Zepbound patent means for expiry and competitive entry.
Sources:
1. https://www.drugpatentwatch.com/